Search Results - "Siena, M"

Refine Results
  1. 1

    Localized Interleukin-12 for Cancer Immunotherapy by Nguyen, Khue G, Vrabel, Maura R, Mantooth, Siena M, Hopkins, Jared J, Wagner, Ethan S, Gabaldon, Taylor A, Zaharoff, David A

    Published in Frontiers in immunology (15-10-2020)
    “…Interleukin-12 (IL-12) is a potent, pro-inflammatory type 1 cytokine that has long been studied as a potential immunotherapy for cancer. Unfortunately, IL-12's…”
    Get full text
    Journal Article
  2. 2

    Dynamic Hydrogels from Host–Guest Supramolecular Interactions by Mantooth, Siena M., Munoz‐Robles, Brizzia G., Webber, Matthew J.

    Published in Macromolecular bioscience (01-01-2019)
    “…Hydrogel biomaterials are pervasive in biomedical use. Applications of these soft materials range from contact lenses to drug depots to scaffolds for…”
    Get full text
    Journal Article
  3. 3

    Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies by Mantooth, Siena M, Abdou, Yara, Saez-Ibañez, Ana Rosa, Upadhaya, Samik, Zaharoff, David A

    Published in Frontiers in immunology (13-05-2024)
    “…Breast cancer poses one of the largest threats to women's health. Treatment continues to improve for all the subtypes of breast cancer, but some subtypes, such…”
    Get full text
    Journal Article
  4. 4

    Excitons in CsPbBr3 Halide Perovskite by Peters, J. A, Liu, Z, Bulgin, O, He, Y, Klepov, V. V, De Siena, M. C, Kanatzidis, M. G, Wessels, B. W

    Published in The journal of physical chemistry letters (30-09-2021)
    “…Excitons in Bridgman grown halide perovskite CsPbBr3 single crystals were examined using photoluminescence (PL) spectroscopy to determine the nature of the…”
    Get full text
    Journal Article
  5. 5

    Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2 by Nguyen, Khue G, Mantooth, Siena M, Vrabel, Maura R, Zaharoff, David A

    Published in Frontiers in immunology (03-05-2022)
    “…Despite the remarkable efficacy of currently approved COVID-19 vaccines, there are several opportunities for continued vaccine development against SARS-CoV-2…”
    Get full text
    Journal Article
  6. 6

    A Scalable and Surfactant-Free Emulsion Method for Producing Microbeads from Varied Biomass Feedstocks by Robertson, Benjamin P., Miller, Audrey J., Rott, Gerald E., Quinn, Siena M., Rahman, Ehsanur, Bachmann, Hannah R., Nistler, Abbie F., Xiong, Boya, Calabrese, Michelle A.

    Published in Langmuir (20-08-2024)
    “…Despite national and international regulations, plastic microbeads are still widely used in personal care and consumer products (PCCPs). These exfoliants and…”
    Get full text
    Journal Article
  7. 7

    Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis by Del Zompo, F, De Siena, M, Ianiro, G, Gasbarrini, A, Pompili, M, Ponziani, F R

    “…Liver involvement of SARS-CoV-2 infection has been reported in several papers, but without homogeneous findings. We aimed to systematically review the…”
    Get more information
    Journal Article
  8. 8

    Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas by Lallemand, D, Manent, J, Couvelard, A, Watilliaux, A, Siena, M, Chareyre, F, Lampin, A, Niwa-Kawakita, M, Kalamarides, M, Giovannini, M

    Published in Oncogene (12-02-2009)
    “…The NF2 gene product, merlin/schwannomin, is a cytoskeleton organizer with unique growth-inhibiting activity in specific cell types. A narrow spectrum of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Focal Cryo-Immunotherapy with Intratumoral IL-12 Prevents Recurrence of Large Murine Tumors by Vrabel, Maura R, Schulman, Jacob A, Gillam, Francis B, Mantooth, Siena M, Nguyen, Khue G, Zaharoff, David A

    Published in Cancers (08-04-2023)
    “…Focal ablation technologies are routinely used in the clinical management of inoperable solid tumors but they often result in incomplete ablations leading to…”
    Get full text
    Journal Article
  11. 11

    Bicuspid Aortic Valve in Children and Young Adults for Cardiologists and Cardiac Surgeons: State-of-the-Art of Literature Review by Nappi, Francesco, Avtaar Singh, Sanjeet Singh, de Siena, Paolo M

    “…Bicuspid aortic valve disease is the most prevalent congenital heart disease, affecting up to 2% of the general population. The presentation of symptoms may…”
    Get full text
    Journal Article
  12. 12

    Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study by Garinis, G.A, Fruci, B, Mazza, A, De Siena, M, Abenavoli, S, Gulletta, E, Ventura, V, Greco, M, Abenavoli, L, Belfiore, A

    Published in International Journal of Obesity (01-08-2010)
    “…Objective: We aimed at evaluating whether the addition of low-dose metformin to dietary treatment could be an effective approach in nondiabetic patients with…”
    Get full text
    Journal Article
  13. 13

    High seizure load during sensitive periods of development leads to broad shifts in ultrasonic vocalization behavior in neonatal male and female C57BL/6J mice by Nolan, Suzanne O., Hodges, Samantha L., Condon, Siena M., Muhammed, Ilyasah D.A., Tomac, Lindsay A., Binder, Matthew S., Reynolds, Conner D., Lugo, Joaquin N.

    Published in Epilepsy & behavior (01-06-2019)
    “…There is increasing evidence that seizures during early development can impact ultrasonic vocalizations (USVs) emitted from neonatal mice. However, most of the…”
    Get full text
    Journal Article
  14. 14

    Characterization of an Injectable Chitosan Hydrogel for the Tunable, Localized Delivery of Immunotherapeutics by Mantooth, Siena M, Hancock, Asher M, Thompson, Peter M, Varghese P J, George, Meritet, Danielle M, Vrabel, Maura R, Hu, Jingjie, Zaharoff, David A

    Published in ACS biomaterials science & engineering (12-02-2024)
    “…Localized delivery of immunotherapeutics within a tumor has the potential to reduce systemic toxicities and improve treatment outcomes in cancer patients…”
    Get full text
    Journal Article
  15. 15

    Introduction of Prenatal Oral Health into Medical Students’ Obstetrics Training by Leone, Siena M., Quinonez, Rocio B., Chuang, Alice, Begue, Amanda, Kerns, Amanda, Jackson, Jeff, Phillips, Ceib

    Published in Journal of dental education (01-12-2017)
    “…The aim of this study was to examine the influence of the Prenatal Oral Health Program (pOHP) at the University of North Carolina at Chapel Hill on medical…”
    Get full text
    Journal Article
  16. 16

    Extended power-law scaling of air permeabilities measured on a block of tuff by Siena, M, Guadagnini, A, Riva, M, Neuman, S. P

    Published in Hydrology and earth system sciences (04-01-2012)
    “…We use three methods to identify power-law scaling of multi-scale log air permeability data collected by Tidwell and Wilson on the faces of a laboratory-scale…”
    Get full text
    Journal Article
  17. 17

    Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment by Ponziani, F R, Scaldaferri, F, De Siena, M, Mangiola, F, Matteo, M V, Pecere, S, Petito, V, Sterbini, F Paroni, Lopetuso, L R, Masucci, L, Cammarota, G, Sanguinetti, M, Gasbarrini, A

    Published in Beneficial microbes (12-10-2020)
    “…Compositional and functional alterations of the gut microbiota are involved in the pathogenesis of several gastrointestinal diseases. Rifaximin is often used…”
    Get more information
    Journal Article
  18. 18

    Safety and Pharmacokinetics of Intravesical Chitosan/Interleukin-12 Immunotherapy in Murine Bladders by Nguyen, Khue G., Wagner, Ethan S., Vrabel, Maura R., Mantooth, Siena M., Meritet, Danielle M., Zaharoff, David A.

    Published in Bladder cancer (13-12-2021)
    “…BACKGROUND: Intravesical administration of interleukin 12 (IL-12) co-formulated with the biopolymer, chitosan (CS/IL-12), has demonstrated remarkable antitumor…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data by Marcellusi, Andrea, Viti, Raffaella, Kondili, Loreta A., Rosato, Stefano, Vella, Stefano, Mennini, Francesco Saverio

    Published in PharmacoEconomics (01-02-2019)
    “…Objective We estimated the cost consequence of Italian National Health System (NHS) investment in direct-acting antiviral (DAA) therapy according to hepatitis…”
    Get full text
    Journal Article